Overweight Clinical Trial
— StepUpOfficial title:
The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults
Hypothesis: Overweight subjects using a Virtual Coach will demonstrate improved adherence to
an exercise regime.
This study is designed to examine the effect of a computer program called a "Virtual Coach"
and find out if it helps people become more active. This program acts as a kind of a
personal trainer and will give you feedback. All participants in the study will receive an
activity monitor to wear during the study and a website to use to track activity. Half of
the participants will also receive the virtual coach software. This software will have to be
downloaded onto your computer, and we will ask that you check in with the coach using the
software three times a week for 12 weeks. The group you will be placed in will be selected
by chance.
| Status | Completed |
| Enrollment | 70 |
| Est. completion date | September 2008 |
| Est. primary completion date | September 2008 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 20 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - Adults age 20-55 inclusive - BMI between 25 and 35 inclusive (overweight and Class 1 obese subjects) - PC Computer with an available USB port, speakers and high-speed internet access in a secure setting (home or private office) - Fluency in English (spoken and written) - Have a Primary Care Physician - Answer "No" to all 7 questions on PAR-Q OR have letter from PCP clearing them to take part in study Exclusion Criteria: - Disability, medical or surgical condition preventing or precluding moderate physical activity. - Cognitive impairment. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | Partners Health Care Center for Connected Health | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Massachusetts General Hospital | FitSense/FitLinxx, Northeastern University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The primary outcome being measured is the level of activity monitored by the activity monitor. Control and Intervention subjects will be encouraged to wear the activity monitor on a daily basis for the 12 week course of the study. | 12 weeks | No | |
| Secondary | Change in subject weight. Subjects will be weighed at their first study visit and their final visit. | 12 weeks | No | |
| Secondary | Change in subject waist circumference. Subjects will be measured at their first study visit and their final visit | 12 weeks | No | |
| Secondary | Subject rating on the working alliance inventory score | 12 weeks, assessed at the end of the study | No | |
| Secondary | Changes in self-efficacy, quality of or readiness to change (as measured through surveys at the beginning and end of the study). | 12 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A | |
| Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |